Google
 
Google

World Stem Cell Summit 2010

Wednesday, February 6, 2008

British Journal of Cancer - Table of Contents alert Volume 98 Issue 3

British Journal of Cancer (BJC) publishes full research papers and
short communications under five broad headings: clinical studies,
translational therapeutics, molecular diagnostics, genetics and
genomics, and epidemiology. BJC also commissions a very successful
series of minireviews on highly topical subjects.
Click here to read two free sample issues online:
http://ealerts.nature.com/cgi-bin24/DM/y/ei2Y0Xztnp0Hhi0EN50Ei

British Journal of Cancer
5 February 2008, Volume 98, Issue 3
Table of Contents

Reviews

517 Clinical pharmacology of cancer therapies in older adults

A Hurria and S M Lichtman

http://ealerts.nature.com/cgi-bin24/DM/y/ei2Y0Xztnp0Hhi0Bm3W0Eb
_____________________________________________________________________

523 G2 checkpoint abrogation and checkpoint kinase-1 targeting in
the treatment of cancer

N Bucher and C D Britten

http://ealerts.nature.com/cgi-bin24/DM/y/ei2Y0Xztnp0Hhi0Bm3X0Ec
_____________________________________________________________________

Clinical Studies

529 The relationship between patients' experiences of continuity of
cancer care and health outcomes: a mixed methods study

M King, L Jones, A Richardson, S Murad, A Irving, H
Aslett, A Ramsay, H Coelho, P Andreou, A Tookman, C Mason
and I Nazareth

http://ealerts.nature.com/cgi-bin24/DM/y/ei2Y0Xztnp0Hhi0Bm3Y0Ed
_____________________________________________________________________

537 Expression of LMO4 and outcome in pancreatic ductal
adenocarcinoma

N C Murphy, C J Scarlett, J G Kench, E Y M Sum, D Segara,
E K Colvin, J Susanto, P H Cosman, C-S Lee, E A Musgrove,
R L Sutherland, G J Lindeman, S M Henshall, J E Visvader
and A V Biankin

http://ealerts.nature.com/cgi-bin24/DM/y/ei2Y0Xztnp0Hhi0Bm3Z0Ee
_____________________________________________________________________

542 Multicenter phase II study of docetaxel plus oxaliplatin
combination chemotherapy in patients with advanced gastric
cancer: Daegu Gyeongbuk Oncology Group

J G Kim, S K Sohn, Y S Chae, H S Song, K-Y Kwon, Y R Do, M
K Kim, K H Lee, M S Hyun, H M Ryoo, S H Bae, K U Park, W S
Lee, J H Baek, H Y Chung and W Yu

http://ealerts.nature.com/cgi-bin24/DM/y/ei2Y0Xztnp0Hhi0Bm3a0El
_____________________________________________________________________

547 Staging investigations for oesophageal cancer: a meta-analysis

E P M van Vliet, M H Heijenbrok-Kal, M G M Hunink, E J
Kuipers and P D Siersema

http://ealerts.nature.com/cgi-bin24/DM/y/ei2Y0Xztnp0Hhi0Bm3b0Em
_____________________________________________________________________

558 First line chemotherapy with planned sequential administration
of gemcitabine followed by docetaxel in elderly advanced
non-small-cell lung cancer patients: a multicenter phase
II study

C Tibaldi, E Vasile, A Antonuzzo, R Di Marsico, A Fabbri,
F Innocenti, G Tartarelli, D Amoroso, M Andreuccetti, M Lo
Dico and A Falcone

http://ealerts.nature.com/cgi-bin24/DM/y/ei2Y0Xztnp0Hhi0Bm3c0En
_____________________________________________________________________

564 CYP1B1 expression is induced by docetaxel: effect on cell
viability and drug resistance

V G Martinez, R O'Connor, Y Liang and M Clynes

http://ealerts.nature.com/cgi-bin24/DM/y/ei2Y0Xztnp0Hhi0Bm3d0Eo
_____________________________________________________________________

571 BORIS, a paralogue of the transcription factor, CTCF, is
aberrantly expressed in breast tumours

V D'Arcy, N Pore, F Docquier, Z K Abdullaev, I Chernukhin,
G-X Kita, S Rai, M Smart, D Farrar, S Pack, V Lobanenkov
and E Klenova

http://ealerts.nature.com/cgi-bin24/DM/y/ei2Y0Xztnp0Hhi0Bm3e0Ep
_____________________________________________________________________

580 Hepatic oxidative DNA damage is associated with increased risk
for hepatocellular carcinoma in chronic hepatitis C

H Tanaka, N Fujita, R Sugimoto, N Urawa, S Horiike, Y
Kobayashi, M Iwasa, N Ma, S Kawanishi, S Watanabe, M Kaito
and Y Takei

http://ealerts.nature.com/cgi-bin24/DM/y/ei2Y0Xztnp0Hhi0Bm3f0Eq
_____________________________________________________________________

587 Distinct expression pattern of the full set of secreted
phospholipases A2 in human colorectal adenocarcinomas:
sPLA2-III as a biomarker candidate

C M Mounier, D Wendum, E Greenspan, J-F Fléjou, D W
Rosenberg and G Lambeau

http://ealerts.nature.com/cgi-bin24/DM/y/ei2Y0Xztnp0Hhi0Bm3g0Er
_____________________________________________________________________

596 Proteomic analysis of stage I primary lung adenocarcinoma aimed
at individualisation of postoperative therapy

J Maeda, T Hirano, A Ogiwara, S Akimoto, T Kawakami, Y
Fukui, T Oka, Y Gong, R Guo, H Inada, K Nawa, M Kojika, Y
Suga, T Ohira, K Mukai and H Kato

http://ealerts.nature.com/cgi-bin24/DM/y/ei2Y0Xztnp0Hhi0Bm3h0Es
_____________________________________________________________________

604 Histone deacetylases 1, 2 and 3 are highly expressed in
prostate cancer and HDAC2 expression is associated with
shorter PSA relapse time after radical prostatectomy

W Weichert, A Röske, V Gekeler, T Beckers, C Stephan, K
Jung, F R Fritzsche, S Niesporek, C Denkert, M Dietel and
G Kristiansen

http://ealerts.nature.com/cgi-bin24/DM/y/ei2Y0Xztnp0Hhi0Bm3i0Et
_____________________________________________________________________

611 Detection of human parvovirus B19 in papillary thyroid carcinoma

J H Wang, W P Zhang, H X Liu, D Wang, Y F Li, W Q Wang, L
Wang, F R He, Z Wang, Q G Yan, L W Chen and G S Huang

http://ealerts.nature.com/cgi-bin24/DM/y/ei2Y0Xztnp0Hhi0Bm3j0Eu
_____________________________________________________________________

619 Microsatellite mutations in buccal cells are associated with
aging and head and neck carcinoma

R J C Slebos, M Li, S Vadivelu, B B Burkey, J L
Netterville, R Sinard, J Gilbert, B Murphy, C H Chung, Y
Shyr and W G Yarbrough

http://ealerts.nature.com/cgi-bin24/DM/y/ei2Y0Xztnp0Hhi0Bm3k0Ev
_____________________________________________________________________

627 Nuclear survivin expression is associated with HPV-independent
carcinogenesis and is an indicator of poor prognosis in
oropharyngeal cancer

S F Preuss, A Weinell, M Molitor, M Stenner, R Semrau, U
Drebber, S J Weissenborn, E J M Speel, C Wittekindt, O
Guntinas-Lichius, T K Hoffmann, G D Eslick and J P
Klussmann

http://ealerts.nature.com/cgi-bin24/DM/y/ei2Y0Xztnp0Hhi0Bm3l0Ew
_____________________________________________________________________

Epidemiology

633 Oral and pharyngeal cancer in South Asians and non-South Asians
in relation to socioeconomic deprivation in South East
England

D R Moles, S Fedele, P M Speight, S R Porter and I dos
Santos Silva

http://ealerts.nature.com/cgi-bin24/DM/y/ei2Y0Xztnp0Hhi0Bm3m0Ex
_____________________________________________________________________

636 Dietary lignans and postmenopausal breast cancer risk by
oestrogen receptor status: a prospective cohort study of
Swedish women

R Suzuki, T Rylander-Rudqvist, S Saji, L Bergkvist, H
Adlercreutz and A Wolk

http://ealerts.nature.com/cgi-bin24/DM/y/ei2Y0Xztnp0Hhi0Bm3n0Ey
_____________________________________________________________________

641 Breast cancer mortality with varying invitational policies in
organised mammography

T Sarkeala, S Heinävaara and A Anttila

http://ealerts.nature.com/cgi-bin24/DM/y/ei2Y0Xztnp0Hhi0Bm3o0Ez
_____________________________________________________________________

646 Age-dependent prevalence of 14 high-risk HPV types in the
Netherlands: implications for prophylactic vaccination and
screening

V M H Coupé, J Berkhof, N W J Bulkmans, P J F Snijders and
C J L M Meijer

http://ealerts.nature.com/cgi-bin24/DM/y/ei2Y0Xztnp0Hhi0Bm3p0E1
_____________________________________________________________________

652 Mobile phone use, exposure to radiofrequency electromagnetic
field, and brain tumour: a case-control study

T Takebayashi, N Varsier, Y Kikuchi, K Wake, M Taki, S
Watanabe, S Akiba and N Yamaguchi

http://ealerts.nature.com/cgi-bin24/DM/y/ei2Y0Xztnp0Hhi0Bm3q0E2
_____________________________________________________________________

660 Correlation of umbilical cord blood haematopoietic stem and
progenitor cell levels with birth weight: implications for
a prenatal influence on cancer risk

W C Strohsnitter, T M Savarese, H P Low, D P Chelmow, P
Lagiou, M Lambe, K Edmiston, Q Liu, I Baik, K L Noller,
H-O Adami, D Trichopoulos and C-C Hsieh

http://ealerts.nature.com/cgi-bin24/DM/y/ei2Y0Xztnp0Hhi0Bm3r0E3
_____________________________________________________________________

664 High birth weight as an important risk factor for infant
leukemia

S Koifman and M S Pombo-de-Oliveira

http://ealerts.nature.com/cgi-bin24/DM/y/ei2Y0Xztnp0Hhi0Bm3s0E4
_____________________________________________________________________

668 Social inequalities in stage at diagnosis of rectal but not in
colonic cancer: a nationwide study

B L Frederiksen, M Osler, H Harling and T Jørgensen

http://ealerts.nature.com/cgi-bin24/DM/y/ei2Y0Xztnp0Hhi0Bm3t0E5
_____________________________________________________________________

Book Review

674 Gene Therapy for Cancer

S Schepelmann and C J Springer

http://ealerts.nature.com/cgi-bin24/DM/y/ei2Y0Xztnp0Hhi0Bm3u0E6
_____________________________________________________________________

Corrigendum

676 BORIS, a paralogue of the transcription factor, CTCF, is
aberrantly expressed in breast tumours

V D'Arcy, N Pore, F Docquier, Z K Abdullaev, I Chernukhin,
G-X Kita, S Rai, M Smart, D Farrar, S Pack, V Lobanenkov
and E Klenova

http://ealerts.nature.com/cgi-bin24/DM/y/ei2Y0Xztnp0Hhi0Bm3v0E7
_____________________________________________________________________


======================================================================

You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department:
registration@nature.com

For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com

For other enquiries, please contact customer feedback department:
feedback@nature.com

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne -
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and
Wales under company number 785998 and whose registered office is located
at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

(c) Copyright 2008 Nature Publishing Group

======================================================================

Google

Any Comments ?.......

E-mail: manojhind2001us@gmail.com
Google
 

World Time